Dr. Emanuela Silva-Alvarenga, MD

Dr. Silva-Alvarenga practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Dr. Silva-Alvarenga's NPI, 1740607803, was assigned on March 26, 2014. Dr. Silva-Alvarenga graduated from Other in 2001. Dr. Silva-Alvarenga holds Florida license 144552.

Dr. Silva-Alvarenga's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Dr. Silva-Alvarenga's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic Florida. Dmand AI also links Dr. Silva-Alvarenga to 2 more medical groups, each named with a free account. Dr. Silva-Alvarenga's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Silva-Alvarenga practices. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Silva-Alvarenga's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Silva-Alvarenga is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dr. Silva-Alvarenga is licensed in Florida.

CMS data shows 314 Medicare services from Dr. Silva-Alvarenga across 8 procedure codes in 2024, for 213 Medicare patients. Medicare paid $30,425 for them.

CMS counts 213 Medicare patients who saw Dr. Silva-Alvarenga in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Silva-Alvarenga's median patient age at 63, with 63% women.

In 2024, Dr. Silva-Alvarenga wrote 170 Medicare Part D claims for 69 patients. 92% of them were for generic drugs. CMS names the drug for 108 of them, across 4 drugs with 11 or more claims each, at $434 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Silva-Alvarenga for performance year 2024, reported through an alternative payment model (APM). Dr. Silva-Alvarenga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of colonoscopy by Dr. Silva-Alvarenga, more than 51% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Silva-Alvarenga, published from 2022 to 2024. 2022 was the busiest year, with 8. The most frequent topics are Rectal Neoplasms, Adenocarcinoma and Laparoscopy. Dr. Silva-Alvarenga has published most often in Am Surg. Dr. Silva-Alvarenga's most frequent co-authors are Steven D. Wexner, MD, David Joel Maron, MD and Arun Nagarajan, MD.

CMS Open Payments shows 42 general payments to Dr. Silva-Alvarenga from 9 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 35% of the total. Intuitive Surgical, Inc. paid the most, $2,344.

Dr. Silva-Alvarenga graduated from Other in 2001.

Dr. Silva-Alvarenga is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.